Maria Babak: Remarkable progress made in cancer treatments over the past 50 years
Maria Babak shared a post by The Babak Lab on LinkedIn, adding:
“What remarkable progress has been made in cancer treatments over the past 50 years!
The evolution from precise surgical techniques to targeted therapies and immunotherapies showcases the relentless pursuit of better, more effective ways to combat cancer.
What stands out most is the balanced perspective on the need to continue exploring diverse treatment approaches beyond the current trends. It’s a reminder that while immunotherapy is making headlines, other vital research areas must not be overlooked. Understanding why some treatments fail and addressing those challenges is crucial for future breakthroughs.
The fight against cancer is far from over, but with continuous advancements and a collaborative effort, we are moving closer to a world where cancer can be effectively treated and potentially cured.
Support the American Cancer Society and The Babak Lab!”
Quoting The Babak Lab’s post:
“Beyond Science Evolution and Future of Cancer Treatments: What Will It Take to End Cancer?
Inspired by Hope Cristol for American Cancer Society.
Discover the groundbreaking advancements in cancer treatment that are shaping the future of oncology. Over the past 50 years, we’ve seen incredible progress, from precise surgeries and tailored radiation therapies to innovative combination treatments that have significantly increased survival rates.
Our latest LinkedIn carousel highlights:
- The rapid acceleration of cancer drug discovery
- Promising new targeted therapies like ONC201
- The exciting potential of immunotherapies, including CAR-T therapy
- Cutting-edge research targeting the MUC1 protein
- Challenges in understanding why some therapies fail
- The importance of diverse approaches beyond immunotherapy
Join us in exploring these advancements and learn how ongoing research and clinical trials are paving the way towards a future free from cancer. Stay informed, support cancer research, and be part of the movement to end cancer as a deadly disease.
Swipe through the carousel to dive deeper into the evolution and future of cancer treatments.”
Source: Maria Babak/LinkedIn and The Babak Lab/LinkedIn
Dr. Maria (Masha) Babak is the Head of The Babak Lab and an Assistant Professor at the City University of Hong Kong. In November 2020, she joined the City University of Hong Kong as an assistant professor. Dr. Babak received the Graeme Hanson-AsBIC Early Career Award in 2022.
Her research interests are at the intersection of chemistry, biology, and medicine, with a focus on the discovery and preclinical development of anticancer drugs for resistant and aggressive cancers with limited treatment options, such as malignant pleural mesothelioma and brain metastases.
